Adrenocorticotropin resistance syndromes

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Familial glucocorticoid deficiency (FGD) and triple A syndrome are rare autosomal recessive disorders.
• These conditions are characterized by insensitivity to adrenocorticotropin (ACTH), leading to impaired steroid biosynthesis in the adrenal cortex.
• While triple A syndrome has diverse clinical features, FGD is specifically defined by glucocorticoid deficiency.

Purpose of the Study:

• To review the clinical and biochemical characteristics of ACTH resistance syndromes.
• To focus on recent advancements in understanding the molecular basis of FGD, particularly the interaction between MC2R and MRAP.
• To elucidate the genetic defects underlying ACTH insensitivity.

Main Methods:

• Review of existing literature on FGD and triple A syndrome.
• Analysis of genetic mutations in MC2R and MRAP.
• Discussion of the functional roles of MC2R and MRAP in ACTH signaling.

Main Results:

• Mutations in the ACTH receptor (MC2R) account for approximately 25% of FGD cases (FGD type 1).
• Mutations in melanocortin receptor accessory protein (MRAP) account for 20% of FGD cases (FGD type 2).
• Approximately 55% of FGD cases lack identifiable genetic defects, suggesting other genes are involved.

Conclusions:

• MRAP is essential for the functional expression of MC2R, acting as an accessory factor.
• Understanding the MC2R-MRAP interaction is crucial for diagnosing and potentially treating FGD.
• Further research is needed to identify the genetic causes of FGD in cases without identified MC2R or MRAP mutations.